GLENMARK - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 3.6
| Stock Code | GLENMARK | Market Cap | 67,571 Cr. | Current Price | 2,394 ₹ | High / Low | 2,474 ₹ |
| Stock P/E | 45.5 | Book Value | 848 ₹ | Dividend Yield | 0.10 % | ROCE | 9.72 % |
| ROE | 7.35 % | Face Value | 1.00 ₹ | DMA 50 | 2,189 ₹ | DMA 200 | 1,992 ₹ |
| Chg in FII Hold | 1.15 % | Chg in DII Hold | -0.81 % | PAT Qtr | 426 Cr. | PAT Prev Qtr | 193 Cr. |
| RSI | 68.4 | MACD | 69.0 | Volume | 4,65,777 | Avg Vol 1Wk | 8,83,874 |
| Low price | 1,340 ₹ | High price | 2,474 ₹ | PEG Ratio | 22.8 | Debt to equity | 0.02 |
| 52w Index | 92.9 % | Qtr Profit Var | 3.00 % | EPS | 0.74 ₹ | Industry PE | 30.2 |
GLENMARK shows mixed signals for swing trading. While the stock has surged strongly with a 52-week index of 92.9% and recent PAT growth, valuation and efficiency metrics raise caution. The P/E ratio of 45.5 is significantly higher than the industry average of 30.2, and the PEG ratio of 22.8 suggests overvaluation relative to growth. Technical indicators (RSI 68.4, MACD 69.0) show strong bullish momentum but nearing overbought territory. The optimal entry price would be near the 50 DMA level of ₹2,180–2,200. If already holding, consider exiting around ₹2,450–2,470, close to recent highs and resistance levels.
✅ Positive
- Strong quarterly PAT growth from ₹193 Cr. to ₹426 Cr.
- High 52-week index (92.9%) shows strong price performance.
- Increase in FII holdings (+1.15%) indicates foreign investor confidence.
- Low debt-to-equity ratio (0.02) ensures financial stability.
⚠️ Limitation
- High P/E ratio (45.5) compared to industry average (30.2).
- PEG ratio (22.8) signals overvaluation relative to growth.
- ROCE (9.72%) and ROE (7.35%) are weak compared to peers.
- Trading volume below 1-week average, reducing short-term liquidity.
📉 Company Negative News
- Decline in DII holdings (-0.81%), showing reduced domestic investor confidence.
- Low EPS (₹0.74) despite high valuation raises concerns.
📈 Company Positive News
- Quarterly profit growth supports earnings momentum.
- Strong foreign institutional investor interest (+1.15%).
- Stock price has shown significant upward momentum over the past year.
🏭 Industry
- Industry P/E is 30.2, lower than GLENMARK’s 45.5, suggesting relative overvaluation.
- Pharmaceutical sector remains resilient with long-term demand drivers.
🔎 Conclusion
GLENMARK is a momentum-driven stock with strong recent performance but stretched valuations and weak efficiency metrics. Entry near ₹2,180–2,200 offers a safer setup, while profit booking should be considered around ₹2,450–2,470. Traders should be cautious of overbought conditions and monitor institutional activity closely.